This year KPMG will be hosting a series of events to coincide with the 41st Annual J.P. Morgan Healthcare Conference. Hear from leading industry luminaries, emerging fast-growth companies, innovative technology creators, and members of the investment community and get forward-thinking perspectives and insights on key life sciences and healthcare topics.
Add KPMG to your agenda:
Additional details on these events can be found below.
Join KPMG and healthcare industry leaders for an executive roundtable to discuss market themes, deal trends and outlook for 2023.
Panelists include:
….along with others from leading health systems and payors. Stay tuned for our additions!
After the session, we invite you to join us and your peers for a networking reception.
Date: Tuesday, January 10, 2023
Time: 3:30 p.m.–5:30 p.m.
Location: KPMG in San Francisco, 55 Second Street, 11th Floor, San Francisco, CA 94105
Join KPMG and industry executives from private equity, payors and large health systems as they discuss macro deal trends and what to expect in 2023.
Date: Wednesday, January 11, 2023.
Time: 8:30 a.m.–5:00 p.m.
Location: InterContinental San Francisco
KPMG and Goodwin are pleased to invite you to our 4th Annual Symposium held during the 41st Annual J.P. Morgan Healthcare Conference week.
As the life sciences industry grapples with changing tides, there remains a wealth of opportunities for companies to come out ahead. During this year’s conference, you will hear from top strategy, legal and financial partners as they engage luminaries across the life sciences and healthcare industries to explore ways life sciences companies can identify and accelerate their R&D programs, maximize value from licensing, M&A, and other transactions, and seize opportunities to raise capital without getting caught in a riptide.
This year, we are pleased to welcome Pablo Legorreta, Founder and CEO of Royalty Pharma, who will deliver our keynote address!
WEDNESDAY, JANUARY 11 | |
9:00 – 9:15 AM | WELCOME REMARKS
|
9:15 – 9:30 AM | IGNITE TALK: HOT TOPICS IN 2023 AND BEYOND IN THE HEALTHCARE REGULATORY ENVIRONMENT
|
9:30 – 10:00 AM | PANEL: AI COLLIDING WITH LIFE SCIENCES: FUNDRAISING, LEGAL, AND OTHER ISSUES WHEN INVESTING IN OR SELLING LIFE SCIENCE COMPANIES THAT INCORPORATE AI PLATFORMS
|
10:00 – 10:45 AM | PANEL: EARLY-STAGE COMPANY: NUTS AND BOLTS OF BUILDING A START-UP AND DRIVING TO SUCCESSFUL FINANCING
|
10:45 – 11:30 AM | PANEL: GLOBAL PRECISION MEDICINE
|
11:30 AM – 12:00 PM | PANEL: EXPLORING THE ECONOMINC AND LEGAL COMPLEXITIES OF IN SILICO RESEARCH AND DRUG DISCOVERY COLLABORATION AGREEMENTS
|
12:00 – 12:45 PM | KEYNOTE ADDRESS: PABLO LEGORETTA, FOUNDER AND CEO, ROYALTY PHARMA |
12:45 – 1:30 PM | LUNCH |
1:30 – 2:15 PM | PANEL: CURRENT TRENDS IN ROYALTY MONETIZATION
|
2:15 – 3:00 PM | FIRESIDE CHAT: THE EVOLVING FTC POLICY AND IMPLICATIONS OF THE DEAL LANDSCAPE
|
3:00 – 3:10 PM | COFFEE BREAK |
3:10 – 3:30 PM | IGNITE TALK: STATE OF THE CAPITAL MARKETS
|
3:30 – 4:15 PM | PANEL: STRATEGIES FOR RAISING CAPITAL IN THE CURRENT MARKET ENVIRONMENT AND GETTING IPO READY
|
4:15 – 5:00 PM | PANEL: STRATEGIES FOR ALTERNATIVE FINANCING FOR PRECOMMERCIAL PUBLIC COMPANIES
|
5:00 – 6:30 PM | COCKTAILS & NETWORKING |
If you like the article above, explore more related content and insights below